Descargar PDF

Otros usuarios también vieron estos artículos

Renal effects of sodium-glucose co-transporter-2 inhibitors in patients with heart failure with reduced or preserved ejection fraction Dimitrios Patoulias; Christodoulos Papadopoulos; Asterios Karagiannis; Michael Doumas;
Nefrologia. 2024;44:584-5
Safety and efficacy of sodium-glucose co-transporter-2 inhibitors and aldosterone inhibitors combinations in chronic kidney disease: A systematic review and meta-analysis Ahmed W. Hageen; Reem Sayad; Alyaa Khaled Abdelmonem; Katia Latifa; Lina Musallam; Moustafa Abouelkheir; Sherif Mira; Ahmed Awad; Ahmed Afsa; Waleed Nassar; Gehad El Ashal; Mohamed Elmasry; Eshak I. Bahbah;
Nefrologia. 2025;45:
Alogliptina y nefritis tubulointersticial: una complicación potencial Byron Chiliquinga Morales; Carmen Martin Varas; Leonardo Calle Garcia; Astrid Rodríguez Gómez; Carlos Santos Alonso; Pablo Sánchez Garrote; Paulo Garcia Gutierrez; Nieves Losada de la Rosa; María José Fernández-Reyes Luis; Ana Saiz González; Angie Tenelanda Santillan;
Nefrologia. 2024;44:755-7